2024 Annual Meeting | PL4 - Contemporary Clinical Issues Plenary Session

Date Monday 04/15/24

Time 09:15 AM - 11:00 AM MDT Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Plenary Session

Director(s) Elizabeth A. Felton, MD, PhD

Topic(s) General Neurology

Learning Objectives This session highilghts issues most critical to practicing neurologists, including abstracts related to new therapeutic developments, clinical applications of basic and translational research, and innovative technical developments already affecting the practice of neurology.

CME Available 1.75 CME credits

Core Competencies Patient Care & Procedural Skills, Medical Knowledge, Practice-based Learning and Improvement

Program Level Intermediate

Recommended Audience Fellow, Resident, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student

Teaching Styles Didactic

Program Evaluations

Event Timeline
09:15 AM - 09:25 AM MDT	Speaker	Presenter: Cutaneous Phosphorylated Alpha-Synuclein Deposition in Dementia with Lewy Bodies and Mild Cognitive Impairment Christopher H. Gibbons, MD, FAAN
09:25 AM - 09:35 AM MDT	Speaker	Discussant: Cutaneous Phosphorylated Alpha-Synuclein Deposition in Dementia with Lewy Bodies and Mild Cognitive Impairment Sonja W. Scholz, MD, FAAN
09:35 AM - 09:45 AM MDT	Speaker	Presenter: The Role of Neurocritical Care Specialists in Brain Death Testing Neil Dhruva, MD
09:45 AM - 09:55 AM MDT	Speaker	Discussant: The Role of Neurocritical Care Specialists in Brain Death Testing Ariane Lewis, MD, FAAN
09:55 AM - 10:05 AM MDT	Speaker	Presenter: The Association Between Neighborhood Disadvantage and Subjective Cognitive Functioning Among Black Women Tanisha Hill-Jarrett
10:05 AM - 10:15 AM MDT	Speaker	Discussant: The Association Between Neighborhood Disadvantage and Subjective Cognitive Functioning Among Black Women Raina Croff, PhD
10:15 AM - 10:25 AM MDT	Speaker	Presenter: Multi-institutional Study of Neurologic Outcomes in People with Multiple Sclerosis Who Are Treated with Immune Checkpoint Inhibitors for Oncologic Indications Prashanth Rajarajan, MD, PhD
10:25 AM - 10:35 AM MDT	Speaker	Discussant: Multi-institutional Study of Neurologic Outcomes in People with Multiple Sclerosis Who Are Treated with Immune Checkpoint Inhibitors for Oncologic Indications Kristin M. Galetta, MD
10:35 AM - 10:45 AM MDT	Speaker	Presenter: Prevalence and Co-morbidities of GI Disorders in Migraine in Large Tertiary Medical Center Natalia Murinova, MD, FAAN
10:45 AM - 10:55 AM MDT	Speaker	Discussant: Prevalence and Co-morbidities of GI Disorders in Migraine in Large Tertiary Medical Center Bridget R. Mueller, MD, PhD

Faculty Disclosures
Elizabeth A. Felton, MD, PhD	Dr. Felton has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbott. Dr. Felton has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Nestle Health Science. Dr. Felton has received personal compensation in the range of $500-$4,999 for serving as a Conference Speaker with American Epilepsy Society.
Christopher H. Gibbons, MD, FAAN	Dr. Gibbons has received personal compensation for serving as an employee of CND Life Sciences. Dr. Gibbons has stock in CND Life Sciences. Dr. Gibbons has received publishing royalties from a publication relating to health care. Dr. Gibbons has received personal compensation in the range of $5,000-$9,999 for serving as a Expert Advisor with Department of Justice.
Sonja W. Scholz, MD, FAAN	Dr. Scholz has received personal compensation for serving as an employee of National Institutes of Health. An immediate family member of Dr. Scholz has received personal compensation for serving as an employee of National Institutes of Health. The institution of Dr. Scholz has received research support from National Institutes of Health. The institution of an immediate family member of Dr. Scholz has received research support from National Institutes of Health. An immediate family member of Dr. Scholz has received intellectual property interests from a discovery or technology relating to health care. Dr. Scholz has a non-compensated relationship as a Scientific Advisory Council Member with Lewy Body Dementia Association that is relevant to AAN interests or activities. Dr. Scholz has a non-compensated relationship as a Editorial Board Member with JAMA Neurology that is relevant to AAN interests or activities. Dr. Scholz has a non-compensated relationship as a Editorial Board Member with Journal of Parkinson's Disease that is relevant to AAN interests or activities. Dr. Scholz has a non-compensated relationship as a Scientific Advisory Board Member with Mission MSA that is relevant to AAN interests or activities. Dr. Scholz has a non-compensated relationship as a Scientific Advisory Board Member with The GBA1 Canada Initiative (G-Can) that is relevant to AAN interests or activities.
Neil Dhruva, MD	Mr. Dhruva has nothing to disclose.
Ariane Lewis, MD, FAAN	Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Seminars in Neurology. Dr. Lewis has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of Clinical Neuroscience.
Tanisha Hill-Jarrett	No disclosure on file
Prashanth Rajarajan, MD, PhD	Dr. Rajarajan has nothing to disclose.
Kristin M. Galetta, MD	Dr. Galetta has received personal compensation in the range of $0-$499 for serving as a Speaker with AAN. Dr. Galetta has received personal compensation in the range of $0-$499 for serving as a Speaker with Can Do MS.
Bridget R. Mueller, MD, PhD	Dr. Mueller has nothing to disclose.
Natalia Murinova, MD, FAAN	Dr. Murinova has nothing to disclose.
Raina Croff, PhD	The institution of Dr. Croff has received research support from Roybal Center for Translational Research. The institution of Dr. Croff has received research support from National Institute on Aging. The institution of Dr. Croff has received research support from National Center for Advancing Translational Science.

��ɫ��

��ɫ��